Koers Regen BioPharma Inc OTC Bulletin Board
Aandelen
US75886M1027
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 236K 219K | Omzet 2023 | 237K 220K | Marktkapitalisatie | 6,33 mln. 5,88 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 2 mln. 1,86 mln. | Nettowinst (verlies) 2023 | 1 mln. 929K | EV/omzet 2022 | 144 x |
Nettoschuld 2022 | 1,22 mln. 1,14 mln. | Nettoschuld 2023 | 635K 590K | EV/omzet 2023 | 29,4 x |
K/w-verhouding 2022 |
13,7
x | K/w-verhouding 2023 |
6,24
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 99,99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 24-04-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 24-04-12 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,96% | 105 mld. | |
-1,43% | 104 mld. | |
+4,40% | 22,94 mld. | |
-12,15% | 22,34 mld. | |
-4,36% | 19,25 mld. | |
-39,98% | 17,08 mld. | |
-10,04% | 16,96 mld. | |
+38,61% | 12,63 mld. | |
+313,59% | 8,49 mld. |